Invest in BioGiant Therapeutics

AI + CRISPR: A $15B+ Market Opportunity

Join us in revolutionizing gene therapy through artificial intelligence. Be part of the next generation of precision medicine that will transform lives worldwide.

Market Size

$15B by 2030

Global gene therapy market growing at 25% CAGR

Differentiator

Proprietary AI Engine

BioG-X1.0 platform with 99.7% prediction accuracy

Traction

Beta Partnerships

50+ enterprise trials simulated, 1M+ datasets processed

Use of Proceeds

R&D & Scaling

Clinical validation, platform development, team expansion

Current Funding Round

$2.5M

Raised to Date

$10M

Series A Target

25%

Progress

Executive Summary

Access our detailed executive summary with password protection

Angel Investor

$25K+

• Quarterly investor updates
• Early access to platform beta
• Investor-only webinars

POPULAR

Strategic Partner

$100K+

• All Angel benefits
• Board observer rights
• Custom integration support
• Priority partnership discussions

Lead Investor

$500K+

• All Strategic benefits
• Board seat consideration
• Co-investment opportunities
• Direct founder access

Ready to Invest?

Contact our team to discuss investment opportunities and access our complete investor package.

For investor pack access: info@biogianttherapeutics.com